FEDERAL FUNDING OPPORTUNITIES
(New!) Call for Nominations: 2025 ODP Early Stage Investigator Lecture
Purpose: to support early career scientists who have made significant research contributions in prevention but who have not yet been awarded an R01 or R01-equivalent NIH research grant. They are particularly interested in nominees conducting applied preventive intervention research to address health disparities in common risk and protective factors for illness, injury, and the leading causes of death in the United States.
Nominations Due: October 25, 2024
Learn More and Apply >>
Notice of Funding Opportunity: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
Purpose: to perform early phase clinical trials to evaluate the biologic effects of preventive agents and interventions and to determine clinically-relevant correlates in order to advance their development for cancer prevention.
Letter of Intent: November 10, 2024
Learn More and Apply >>
Notice of Funding Opportunity: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
Purpose: to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer.
Letter of Intent: November 10, 2024
Learn More and Apply >>
Notice of Funding Opportunity: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
Purpose: to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer.
Letter of Intent: November 10, 2024
Learn More and Apply >>
Notice of Funding Opportunity: NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
Purpose: To encourage those who want to continue to participate in the NCI clinical trials networks through leadership in the: development of national clinical trials, implementation of NCI clinical trials in their institutions and national service to the NCI clinical trials networks through participation in the scientific review committees.
Application: November 5, 2024
Learn More and Apply >>
Notice of Funding Opportunity: RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed) (RFA-CA-24-029)
Purpose: Promote fundamental studies in the emerging area of RNA modifications that underlie the oncogenic process, focusing on the central role of RNA modifications in translational reprogramming of cancer cells
Letter of Intent: October 5, 2024
Learn More and Apply >>
NCI Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
Focus area: Address barriers to care that contribute to disparities in health outcomes for childhood cancer survivors, and/or that focus on high-risk groups such as the uninsured/under-insured
$499k per year for up to 5 years
Preliminary Application: October 11, 2024
Learn More and Apply >>
Notice of Special Interest: Conferences and Scientific Meetings in Cancer Biology
Purpose: Support innovative conferences, symposia, and workshops that explore basic, fundamental questions in areas of cancer biology
Application: December 12, 2024
Learn More and Apply >>
Congressionally Directed Medical Research Programs (CDMRP)
FY24 Breast Cancer Research Program (BCRP) - next deadline September 26, 2024
FY24 Bone Marrow Failure Research Program (BMFRP) - next deadline October 9, 2024
FY24 Kidney Cancer Research Program (KCRP) - next deadline September 24, 2024
FY24 Pancreatic Cancer Research Program (PCARP) - next deadline October 3, 2024
FY24 Peer-Reviewed Cancer Research Program (PRCRP) - next deadline October 15, 2024
|